Immunohistochemical assessment of localization and frequency of micrometastases in lymph nodes of colorectal cancer.

PURPOSE Micrometastases are often found in regional lymph nodes of colorectal cancer (CRC). The aim of this study is to examine the extent and distribution of such lymph nodes. EXPERIMENTAL DESIGN We immunohistochemically assessed localization and frequency of micrometastases in 878 lymph nodes from 98 patients with CRC. The anatomical position of lymph nodes was defined as level 1 to level 3 according to distance from the main tumor. RESULTS The frequency of micrometastasis increased through observation of the 4-microm-thick lymph node sections, from one to two to five slices. With five slices, micrometastasis was frequently and extensively present in 49.1, 35.7, and 53.3% patients of histologically node-negative patients, node-positive patients at level 1, and node-positive patients at level 2, respectively. We then assessed the value of the presence of micrometastasis in node-negative patients with regard to prognosis, but no significant impact was obtained. To examine the reproducibility of the results obtained with immunohistochemistry, serial sectioning (four consecutive slices at seven different levels) of lymph nodes was additionally performed in lymph nodes initially diagnosed as micrometastasis positive. Immunohistochemical detection revealed that the sectioning level highly affected the results. CONCLUSIONS Our results indicated frequent presence of micrometastasis in lymph nodes of CRC and that micrometastasis in node-negative CRC patients did not help in predicting the outcome, in part because of the limited reproducibility with immunohistochemistry.

[1]  S. Kitano,et al.  Pattern of Lymph Node Micrometastasis and Prognosis of Patients with Colorectal Cancer , 2001, Annals of Surgical Oncology.

[2]  M. Monden,et al.  Extensive micrometastases to lymph nodes as a marker for rapid recurrence of colorectal cancer: a study of lymphatic mapping. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  A. Carlin,et al.  Guidelines 2000 for colon and rectal cancer surgery. , 2001, Journal of the National Cancer Institute.

[4]  F. Sato,et al.  Lymph node micrometastasis and prognosis in patients with oesophageal squamous cell carcinoma , 2001, The British journal of surgery.

[5]  S. Natsugoe,et al.  Detection and Prediction of Micrometastasis in the Lymph Nodes of Patients With pN0 Gastric Cancer , 2001, Annals of Surgical Oncology.

[6]  M. Monden,et al.  Genetic detection for micrometastasis in lymph node of biliary tract carcinoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[7]  M Monden,et al.  Overexpression of CDC25B phosphatase as a novel marker of poor prognosis of human colorectal carcinoma. , 2000, Cancer research.

[8]  M. Monden,et al.  Quantification of micrometastases in lymph nodes of colorectal cancer using real-time fluorescence polymerase chain reaction. , 2000, International journal of oncology.

[9]  M. Ikeguchi,et al.  Micrometastasis in lymph nodes and microinvasion of the muscularis propria in primary lesions of submucosal gastric cancer. , 2000, Surgery.

[10]  K. Hatakeyama,et al.  Significance of immunohistochemically demonstrated micrometastases to lymph nodes in esophageal cancer with histologically negative nodes. , 2000, Surgery.

[11]  M. Nozue,et al.  Prognostic significance of perirectal lymph node micrometastases in Dukes' B rectal carcinoma: an immunohistochemical study by CAM5.2. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[12]  R. Stenling,et al.  Are lymph node micrometastases of any clinical significance in dukes stages A and B colorectal cancer? , 1998, Diseases of the colon and rectum.

[13]  M. Feith,et al.  Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma , 1998, Cancer.

[14]  C. V. D. van de Velde,et al.  Micrometastases and survival in stage II colorectal cancer. , 1998, The New England journal of medicine.

[15]  S. Pileri,et al.  The EnVision++ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques. , 1998, Journal of clinical pathology.

[16]  G. Cattoretti,et al.  Localization and expression of p27KIP1 in multistage colorectal carcinogenesis. , 1998, Cancer research.

[17]  A. Niendorf,et al.  Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. , 1997, The New England journal of medicine.

[18]  H. Frierson,et al.  Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors. , 1996, Clinical chemistry.

[19]  L. Hakansson,et al.  Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes' B colorectal carcinoma: an immunohistochemical study. , 1996, The European journal of surgery = Acta chirurgica.

[20]  Y. Maehara,et al.  Clinical significance of occult micrometastasis lymph nodes from patients with early gastric cancer who died of recurrence. , 1996, Surgery.

[21]  K. Mimori,et al.  Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. , 1995, Cancer research.

[22]  M. Ogawa,et al.  Genetic diagnosis of lymph-node metastasis in colorectal cancer , 1995, The Lancet.

[23]  D. Gouma,et al.  Role of extended lymph node dissection in the treatment of gastrointestinal tumours: a review of the literature. , 1995, Scandinavian journal of gastroenterology. Supplement.

[24]  A. Nicholson,et al.  Effect on lymph node status of triple levelling and immunohistochemistry with CAM 5.2 on node negative colorectal carcinomas. , 1994, Gut.

[25]  K. Sugimachi,et al.  The distribution of lymph node metastases in right-sided colon cancer. , 1994, Journal of clinical gastroenterology.

[26]  J. Greenson,et al.  Identification of occult micrometastases in pericolic lymph nodes of Dukes' B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long‐term survival , 1994, Cancer.

[27]  M. Toner,et al.  The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma , 1994, The Journal of pathology.

[28]  M. J. Lopez,et al.  Role of extended resection in the initial treatment of locally advanced colorectal carcinoma. , 1993, Surgery.

[29]  R. Grace,et al.  The importance of combining xylene clearance and immunohistochemistry in the accurate staging of colorectal carcinoma. , 1992, Journal of the Royal Society of Medicine.

[30]  N. Haboubi,et al.  The importance of combining xylene clearance and immunohistochemistry in the accurate staging of colorectal carcinoma. , 1992, Journal of the Royal Society of Medicine.

[31]  V. Alves,et al.  Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins , 1991, Diseases of the colon and rectum.